- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-376
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.8¢ |
Change
-0.013(1.29%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $1.989M | 2.060M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 48073 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 56106 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 48073 | 0.955 |
22 | 108964 | 0.950 |
20 | 252498 | 0.945 |
18 | 289023 | 0.940 |
12 | 332620 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 52952 | 17 |
0.965 | 116529 | 20 |
0.970 | 176063 | 15 |
0.975 | 179931 | 11 |
0.980 | 227573 | 10 |
Last trade - 14.10pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online